Biofluid assay for peptide-related and other drugs
Author(s)
Bibliographic Information
Biofluid assay for peptide-related and other drugs
（Methodological surveys in bioanalysis of drugs, v. 24）（Special publication / Royal Society of Chemistry, 185）
Royal Society of Chemistry, Information Services, c1996
Available at / 3 libraries
-
No Libraries matched.
- Remove all filters.
Note
"based on the proceedings of the 11thInternational Bioanalytical Forum mounted by the Forum Syndicate of the Chromatographic Society, entitled Biofluid Assay for Peptide-related and Other Drugs, held 29 August to 1 September 1995, in Guildford, UK"
Description and Table of Contents
Description
This volume is part of a series aimed at encouraging discussion between bioanalysts. Topics covered include: peptide-type agents; agents with peptide-type targets; drug analytes; and approaches for analytical separation and detection.
Table of Contents
- Peptide-type agents: Unique issues and analytical methods for pharmacokinetics and metabolism studies with protein/peptide pharmaceuticals, Marjorie A. Mohler et al
- Immuno and other "biological" approaches in pharmacokinetics, D. Gygax et al
- Analytical strategies for a new peptide drug, R.F. Venn et al
- A sensitive sandwich chemiluminescent enzyme immunoassay for the determination of administered salmon calcitonin in human plasma, S.H. Hsu et al
- Analytical procedures for monitoring high mol. wt. fragments derived from the rRicin immunotoxin ZD 0490 in human plasma, S.J. Bacon et al
- Sample preparation and subsequent steps: strategies for peptides and peptidomimetics, H.M. Hill et al
- LC-MS profiling of peptidomimetics and peptides from biological sources, G.C. Didonato et al. Agents with peptide-type targets: Development and cross-validation of RIA and LC-MS-MS- methods for determining the fibrinogen-receptor antagonist L-734,217 in plasma, J.D. Gilbert et al
- Retention of fibrinogen in ion-exchange HPLC: evidence for a domain binding model, Y. Liu, D.J. Anderson
- Bioanalitical strategies to support the development of an HIV protease inhibitor, including GC-MS, HPLC and chiral analysis, C.A. James et al
- Analysis of pseudopeptidyl matrix metalloproteinase inhibitors in plasma, J. Moore et al. Various drug analytes - problems and strategies: Brain distribution of CNS-active drug studies by microdialysis coupled with MS-MS (TSP) in flow injection mode, C. Nuez et al
- A highly sensitive GC method for determining deramciclane and its N-des metabolite in rat and dog plasma, Katalin B. Nemes et al
- A sensitive, specific and rugged determination of flesinoxan in plasma by HPLC-EC, D.J.K. van der Stel et al
- Determination of the 5-HT receptor agonist 311C90 in human plasma by LC-MS-MS, S. Pleasance et al
- LC-MS-MS assay of fenticonazole in human plasma, T.A. Enos et al
- Development and application of the LC-MS-MS bioanalytical assays - myths and realities!, R.J. Simmonds et al
- A strategy for the development of bioanalytical methods using LC-MS, C. Mason et al
- Ultra-trace bioanalysis: three approaches for assay of a novel pharmaceutical at the pg/ml level, M. Bayliss et al
- Drug bioanalysis made easy? W.J. Lough et al
- Fluorometric detection of non-fluorescent quinolones after post-collum photoreaction, K. Borner et al
- Compounds posing an endogenous blank problem: retinoids, T.A.G. Noctor
- Chiral-HPLC resolution of carboxyibuprofen, a major urinary metabolite of ibuprofen, S.C. Tan et al
- An HPLC assay directly on plasma using an ISRP, S. Braggio, R.J. Barnaby. (Part contents).
by "Nielsen BookData"